Zerodha's Nithin Kamath says India's response to affordable weight-loss drugs is 'weird'. Here's why

Generic GLP-1 weight-loss drugs have become significantly more affordable in India, but adoption remains slower than expected. Zerodha co-founder Nithin Kamath believes the issue isn't cost but long-term commitment, self-injections and cons